⎜Lincurve's home HIFU device and live demonstration booth expand consumer brand awareness 

By Insun Jang | insun@k-health.com | Published March 24, 2026 

Global partners and distributors at the Newpong booth

Newpong has concluded its participation in KIMES 2026 — held March 19–22 at COEX in Seoul — announcing that the exhibition successfully reinforced the company's standing in the ultrasound medical device market. 

Newpong used the platform to simultaneously demonstrate the depth of its clinical technology and signal the broader direction of its product expansion, drawing sustained attention from visitors in both medical and consumer segments. 

On the clinical side, Newpong anchored its hospital-grade lineup with two key products. Lincurve Pro — featuring the patented Concave Technology™ — drew particular interest from dermatologists and plastic surgeons for its curved transducer design, which conforms to the natural contours of the face, delivering more precise ultrasound energy while reducing procedural discomfort. LSSA, equipped with the world's smallest-diameter facial probe (0.9mm) alongside a body probe, enables selective, site-specific fat dissolution and is already in active clinical use across multiple facilities. 

Throughout the exhibition, Newpong led in-depth consultations on device adoption and clinical application, foregrounding the clinical evidence and technology safety profile of its products. Notably, the company held individual strategy meetings with distributors and partners from key Asian markets — including Taiwan, Japan, Thailand, and Hong Kong — to discuss country-specific distribution structures and product positioning in concrete terms. These discussions are intended to accelerate Newpong's market development across Asia. 

On the consumer side, Lincurve — Newpong's home HIFU device — attracted strong interest from both international visitors and general attendees. Lincurve shares the same cartridge architecture as Lincurve Pro but incorporates an output design calibrated for non-professional use. 

The response on the exhibition floor confirmed for Newpong that the ultrasound technology developed for clinical settings has genuine potential as a consumer device. 

"KIMES served as an opportunity to both validate the technical maturity of our clinical devices and publicly present the expanded application of our ultrasound platform," said a Newpong representative. "We will continue to strengthen our global partnerships going forward." 

Newpong operates an aesthetic and therapeutic portfolio built on ultrasound technology and is actively pursuing expansion across global markets. 


► View original source
https://www.k-health.com/news/articleView.html?idxno=90912